Latest news and articles about wegovy from NEX English
Novo Nordisk has announced new study results confirming that high-dose Wegovy injections help patients lose nearly 28% of their weight over 72 weeks. This announcement follows the launch of the new dosage in the United States just a month ago.
Novo Nordisk has achieved the best obesity drug launch this year with its medication Wegovy, surpassing 600,000 prescriptions. This move comes as Eli Lilly intensifies competition by introducing new pills to attract patients.
Novo Nordisk announced a rise in its shares by up to 4% following a recommendation from the National Institute for Health and Care Excellence (NICE) in England to use Wegovy as a treatment for preventing heart attacks and strokes. This decision significantly expands patient access to this effective treatment within the English healthcare system.